Compounds for the treatment of metabolic disorders

Details for Australian Patent Application No. 2007220868 (hide)

Owner Wellstat Therapeutics Corporation

Inventors Sharma, Shalini; Von Borstel, Reid W.

Agent FB Rice

Pub. Number AU-B-2007220868

PCT Pub. Number WO2007/101060

Priority 60/777,678 28.02.06 US

Filing date 22 February 2007

Wipo publication date 7 September 2007

Acceptance publication date 9 June 2011

International Classifications

C07D 263/00 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

A01N 31/14 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds

A61K 31/075 (2006.01) - Ethers or acetals

Event Publications

21 August 2008 PCT application entered the National Phase

  PCT publication WO2007/101060 Priority application(s): WO2007/101060

9 June 2011 Application Accepted

  Published as AU-B-2007220868

6 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007220873-Method and apparatus for minimizing noise in a transmitter

2007220866-Transverse flux electric inductors